Targeting Kv1.3 K+ channels in effector memory T cell for the therapy of autoimmune diseases.

被引：0
|
作者：
Beeton, C
Wulff, H
Pennington, MW
Calabresi, PA
Wang, PH
LeeHealey, CJ
Andrews, BS
Chandy, KG
机构：
[1] UC Irvine, Irvine, CA USA
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Bachem Biosci Inc, King Of Prussia, PA USA
[4] Johns Hopkins Univ Hosp, Baltimore, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S491 / S492
页数：2
相关论文
共 50 条
  • [1] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases
    Beeton, C
    Pennington, MW
    Wulff, H
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, PA
    Chen, CY
    Gutman, GA
    Chandy, KG
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (04) : 1369 - 1381
  • [2] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for the therapy of autoimmune diseases
    Becton, C
    Pennington, MW
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, P
    Chandy, KG
    [J]. FASEB JOURNAL, 2005, 19 (04): : A344 - A345
  • [3] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels: Implication for therapy of autoimmune diseases
    Beeton, C
    Pennington, MW
    Wulff, H
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, P
    Chen, CY
    Chandy, KG
    [J]. BIOPOLYMERS, 2005, 80 (04) : 571 - 571
  • [4] A small molecule Kv1.3 blocker, for the treatment of effector memory T-cell mediated autoimmune diseases.
    Azam, Philippe
    Sankaranarayanan, Ananthakrishnan
    Homerick, Daniel
    Wulff, Heike
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S45 - S46
  • [5] Targeting effector memory T-cells with Kv1.3 blockers
    Wulff, Heike
    Pennington, Michael
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (04) : 438 - 445
  • [6] Kv1.3 channels: therapeutic target for T cell-mediated autoimmune diseases
    Beeton, C.
    Wulff, H.
    Standifer, N. E.
    Mullen, K. M.
    Azam, P.
    Kolski-Andreaco, A.
    Wei, E.
    Grino, A.
    Counts, D. R.
    Wang, P. H.
    LeeHealey, C. J.
    Andrews, B. S.
    Pennington, M. W.
    Knaus, H. G.
    Nepom, G. T.
    Gutman, G. A.
    Calabresi, P. A.
    Chandy, K. G.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S148 - S148
  • [7] Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
    Beeton, Christine
    Wulff, Heike
    Standifer, Nathan E.
    Azam, Philippe
    Mullen, Katherine M.
    Pennington, Michael W.
    Kolski-Andreaco, Aaron
    Wei, Eric
    Grino, Alexandra
    Counts, Debra R.
    Wang, Ping H.
    LeeHealey, Christine J.
    Andrews, Brian S.
    Sankaranarayanan, Ananthakrishnan
    Homerick, Daniel
    Roeck, Werner W.
    Tehranzadeh, Jamshid
    Stanhope, Kimber L.
    Zimin, Pavel
    Havel, Peter J.
    Griffey, Stephen
    Knaus, Hans-Guenther
    Nepom, Gerald T.
    Gutman, George A.
    Calabresi, Peter A.
    Chandy, K. George
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) : 17414 - 17419
  • [8] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels: implication for multiple sclerosis therapy
    Beeton, C
    Pennington, MW
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Langer, J
    Calabresi, P
    Chandy, KG
    [J]. BIOPHYSICAL JOURNAL, 2005, 88 (01) : 279A - 279A
  • [9] Kv1.3 channels: Therapeutic target for T cell-mediated autoimmune diseases
    Monaghan, Kevin P.
    Beeton, Christine
    Wulff, Heike
    Calabresi, Peter
    Chandy, George K.
    [J]. NEUROLOGY, 2007, 68 (12) : A339 - A340
  • [10] Targeting Kv1.3 channels on T cells
    Carney, Ellen F.
    [J]. NATURE REVIEWS NEPHROLOGY, 2021, 17 (03) : 152 - 152
12345